GSK3B
From Wikipedia, the free encyclopedia
Glycogen synthase kinase 3 beta
|
|||||||||||
PDB rendering based on 1gng. | |||||||||||
Available structures: 1gng, 1h8f, 1i09, 1j1b, 1j1c, 1o9u, 1pyx, 1q3d, 1q3w, 1q41, 1q4l, 1q5k, 1r0e, 1uv5 | |||||||||||
Identifiers | |||||||||||
Symbol(s) | GSK3B; | ||||||||||
External IDs | OMIM: 605004 MGI: 1861437 HomoloGene: 55629 | ||||||||||
|
|||||||||||
RNA expression pattern | |||||||||||
Orthologs | |||||||||||
Human | Mouse | ||||||||||
Entrez | 2932 | 56637 | |||||||||
Ensembl | ENSG00000082701 | ENSMUSG00000022812 | |||||||||
Uniprot | P49841 | Q3TB31 | |||||||||
Refseq | NM_002093 (mRNA) NP_002084 (protein) |
NM_019827 (mRNA) NP_062801 (protein) |
|||||||||
Location | Chr 3: 121.03 - 121.3 Mb | Chr 16: 38.01 - 38.17 Mb | |||||||||
Pubmed search | [1] | [2] |
Glycogen synthase kinase 3 beta, also known as GSK3B, is a human gene.
Glycogen synthase kinase-3 (GSK3) is a proline-directed serine-threonine kinase that was initially identified as a phosphorylating and inactivating glycogen synthase. Two isoforms, alpha (GSK3A; MIM 606784) and beta, show a high degree of amino acid homology (Stambolic and Woodgett, 1994). GSK3B is involved in energy metabolism, neuronal cell development, and body pattern formation (Plyte et al., 1992).[supplied by OMIM][1]
[edit] References
[edit] Further reading
- Plyte SE, Hughes K, Nikolakaki E, et al. (1993). "Glycogen synthase kinase-3: functions in oncogenesis and development.". Biochim. Biophys. Acta 1114 (2-3): 147-62. PMID 1333807.
- Morishima-Kawashima M, Hasegawa M, Takio K, et al. (1995). "Hyperphosphorylation of tau in PHF.". Neurobiol. Aging 16 (3): 365-71; discussion 371-80. PMID 7566346.
- Jope RS, Bijur GN (2002). "Mood stabilizers, glycogen synthase kinase-3beta and cell survival.". Mol. Psychiatry 7 Suppl 1: S35-45. doi: . PMID 11986994.
- Bhat RV, Budd SL (2003). "GSK3beta signalling: casting a wide net in Alzheimer's disease.". Neurosignals 11 (5): 251-61. doi: . PMID 12566926.
- Nadri C, Kozlovsky N, Agam G (2003). "[Schizophrenia, neurodevelopment and glycogen synthase kinase-3]". Harefuah 142 (8-9): 636-42, 644. PMID 14518171.
- Mulholland DJ, Dedhar S, Wu H, Nelson CC (2006). "PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer.". Oncogene 25 (3): 329-37. doi: . PMID 16421604.